Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 205

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray

Open access
de Assis, Rafael R., Jain, Aarti, Nakajima, Rie, Jasinskas, Algis, Felgner, Jiin, Obiero, Joshua M., Norris, Philip J., Stone, Mars, Simmons, Graham, Bagri, Anil, Irsch, Johannes, Schreiber, Martin, Buser, Andreas, Holbro, Andreas, Battegay, Manuel, Hosimer, Philip, Noesen, Charles, Adenaiye, Oluwasanmi, Tai, Sheldon, Hong, Filbert, Milton, Donald K., Davies, D. Huw, Contestable, Paul, Corash, Laurence M., Busch, Michael P., Felgner, Philip L., Khan, Saahir · 2021 · Nature Communications

Abstract

The current practice for diagnosis of COVID-19, based on SARS-CoV-2 PCR testing of pharyngeal or respiratory specimens in a symptomatic patient at high epidemiologic risk, likely underestimates the true prevalence of infection. Serologic methods can more accurately estimate the disease burden by detecting infections missed by the limited testing performed to date. Here, we describe the validation of a coronavirus antigen microarray containing immunologically significant antigens from SARS-CoV-2, in addition to SARS-CoV, MERS-CoV, common human coronavirus strains, and other common respiratory viruses. A comparison of antibody profiles detected on the array from control sera collected prior to the SARS-CoV-2 pandemic versus convalescent blood specimens from virologically confirmed COVID-19 cases demonstrates near complete discrimination of these two groups, with improved performance from use of antigen combinations that include both spike protein and nucleoprotein. This array can be used as a diagnostic tool, as an epidemiologic tool to more accurately estimate the disease burden of COVID-19, and as a research tool to correlate antibody responses with clinical outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-020-20095-2

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 205

Metadata

Authors
de Assis, R. R., Jain, A., Nakajima, R., Jasinskas, A., Felgner, J., Obiero, J. M., Norris, P. J., Stone, M., Simmons, G., Bagri, A., Irsch, J., Schreiber, M., Buser, A., Holbro, A., Battegay, M., Hosimer, P., Noesen, C., Adenaiye, O., Tai, S., Hong, F., Milton, D. K., Davies, D. H., Contestable, P., Corash, L. M., Busch, M. P., Felgner, P. L., & Khan, S.
Venue
Nature Communications
Published
2021-01-04
Volume
12
Issue
1
Pages
6-6
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3118781919
Cited by
205
References
4
FWCI
12.59
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray. https://app.cochat.ai/papers/10.1038/s41467-020-20095-2
The paper
de Assis, R. R., Jain, A., Nakajima, R., Jasinskas, A., Felgner, J., Obiero, J. M., Norris, P. J., Stone, M., Simmons, G., Bagri, A., Irsch, J., Schreiber, M., Buser, A., Holbro, A., Battegay, M., Hosimer, P., Noesen, C., Adenaiye, O., Tai, S., . . . Khan, S. (2021). Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray. Nature Communications. https://doi.org/10.1038/s41467-020-20095-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.